Red Tortoise LLC’s Generation Bio GBIO Stock Holding History

Red Tortoise LLC’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-33	Closed	-$1.83K	–	566
2023 Q2	$1.83K	Buy	+33	New	+$1.51K	﹤0.01%	476

Other funds holding GBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Red Tortoise LLC's GBIO Position: Q3 2023 in Review

Red Tortoise LLC sold out of Generation Bio (GBIO) in Q3 2023, closing a stake of 33 shares — an estimated $1.83K sold.

Red Tortoise LLC first reported a position in GBIO in Q2 2023 and held it in 1 quarter. The position peaked at $1.83K in Q2 2023. 75 funds tracked by Wall St. Rank hold GBIO as of Q3 2023.

Red Tortoise LLC reported no remaining Generation Bio position as of Q3 2023 after selling out during the quarter.
Red Tortoise LLC sold 33 Generation Bio shares in Q3 2023, an estimated $1.83K.
Red Tortoise LLC first reported a position in Generation Bio in Q2 2023 and held it in 1 quarter.
Red Tortoise LLC's Generation Bio position peaked at $1.83K in Q2 2023.
75 funds tracked by Wall St. Rank held Generation Bio as of Q3 2023.

Based on Red Tortoise LLC's 13F filing for Q3 2023, filed 2 Nov 2023.